Analysts Set Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Price Target at $3.33
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) has been given a consensus rating of “Hold” by the five research firms that are presently covering the firm, Marketbeat reports. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 1 year target […]
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) has been given a consensus rating of “Hold” by the five research firms that are presently covering the firm, Marketbeat reports. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 1 year target […]
